Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
7.70
-0.02 (-0.26%)
Jun 14, 2024, 9:51 AM EDT - Market open

Acrivon Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-60.39-31.17-16.24-5.31
Depreciation & Amortization
1.311.10.830.01
Share-Based Compensation
11.622.190.50
Other Operating Activities
4.82-2.230.932.49
Operating Cash Flow
-42.64-30.12-13.98-2.8
Capital Expenditures
-1.29-2.17-0.24-0.02
Change in Investments
52.01-139.5100
Investing Cash Flow
50.72-141.68-0.24-0.02
Share Issuance / Repurchase
0.78104.4800
Debt Issued / Paid
0000.06
Other Financing Activities
-2.33-2.77112.222.83
Financing Cash Flow
-1.55101.71112.222.89
Net Cash Flow
6.52-70.08980.07
Free Cash Flow
-43.93-32.28-14.22-2.82
Free Cash Flow Per Share
-1.99-7.83-8.16-1.97
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).